You are currently viewing a new version of our website. To view the old version click .
Medicina
  • Correction
  • Open Access

7 November 2025

Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638

,
,
,
,
,
,
,
,
and
1
Department of Medical Oncology, Mardin Training and Research Hospital, Mardin 47100, Türkiye
2
Department of Medical Oncology, Van Yuzuncu Yil University Faculty of Medicine, Van 65100, Türkiye
3
Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye
4
Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye

Error in Figure

In the original publication, there was a mistake in Figure 2 as published [1]. Only the Kaplan–Meier curve needs to be updated because it is currently identical to the one in Figure 1. The corrected Figure 2 is as follows. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 2. PFS3 Kaplan–Meier survival analysis according to treatment regimens.

Reference

  1. Kalkan, Z.; Ebinc, S.; Arcagok, M.; Bilici, A.; Yildiz, O.; Kilickap, S.; Guven, D.C.; Tatli, A.M.; Sumbul, A.T.; Mandel, N.M.; et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.